Premium
Children and COVID‐19: Microbiological and immunological insights
Author(s) -
Buonsenso Danilo,
Sali Michela,
Pata Davide,
De Rose Cristina,
Sanguinetti Maurizio,
Valentini Piero,
Delogu Giovanni
Publication year - 2020
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.24978
Subject(s) - medicine , pandemic , covid-19 , coronavirus , population , betacoronavirus , immunology , pediatrics , intensive care medicine , virology , environmental health , disease , outbreak , infectious disease (medical specialty) , pathology
Since its first description in China, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has spread worldwide being declared a pandemic by the World Health Organization. More than 10.3 million people have been infected and more than 506 000 people died. However, SARS‐CoV‐2 had a lower impact on the pediatric population. Only about 1% to 2% of infected people are children and few deaths under the age of 14 are described so far. In this article, we discuss microbiological and immunological characteristics of SARS‐CoV‐2 infection in children highlighting the main differences from adult SARS‐CoV‐2 infection.